Company Overview
Snapshot
Founded in February 2021 by Avi Domb, Nexocarp operates with 1–10 employees. The company has secured Seed funding from Racah Nano Venture Fund. In February 2021, Nexocarp received Seed funding, leveraging its proprietary technology developed at the Hebrew University of Jerusalem.
Business overview
Nexocarp specializes in providing sustainable microencapsulation solutions for various industries, including cosmetics, agrochemicals, food, and pharmaceuticals. The company's core technology, developed at the Hebrew University of Jerusalem, focuses on all-natural microencapsulation products. Nexocarp operates within the Health Tech & Life Sciences sector, with applications spanning pharmaceuticals, cosmetics, and the food industry, addressing B2B markets with its R&D stage products.
Log in to access full profile ›Company Intelligence Q&A
- What is Nexocarp's primary focus?
- Nexocarp focuses on developing and offering novel, sustainable microencapsulation solutions, particularly all-natural products, for leading players in industries such as cosmetics, agrochemicals, food, and pharmaceuticals.
- When was Nexocarp founded?
- Nexocarp was founded in February 2021.
- Who is a key founder of Nexocarp?
- Avi Domb is a co-founder and CTO of Nexocarp.
- What is the origin of Nexocarp's core technology?
- Nexocarp's encapsulation method is based on proprietary technology developed at the Hebrew University of Jerusalem.
- Which investor participated in Nexocarp's Seed funding round?
- In February 2021, Nexocarp received Seed funding from Racah Nano Venture Fund.